Trial ID or NCT#

NCT00375830

Status

NOT RECRUITING

Purpose

This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate cancer.

Official Title

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Andrei Iagaru
Radiologist
Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center
Sanjiv Sam Gambhir, MD, PhD
Robert Herfkens
Radiologist
Professor of Radiology (Cardiovascular Imaging)
Shreyas Vasanawala, MD/PhD
Radiologist
Professor of Radiology (Pediatric Radiology)

Contact us to find out if this trial is right for you.

CONTACT

CCTO
(650) 498-7061